Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain

Pain

Volumn 139, Issue 1, 2008, Pages 117-126

  Osikowicz, Maria ^a   Mika, Joanna ^a   Makuch, Wioletta ^a   Przewlocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

AMN082; LY379268; Morphine; MPEP; Neuropathic pain

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; AMN 082; GLUTAMATE RECEPTOR; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 7; MORPHINE; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CHRONIC PAIN; COLD; DRUG POTENTIATION; HYPERALGESIA; LOW DRUG DOSE; MALE; MORPHINE TOLERANCE; MOUSE; MOUSE STRAIN; NERVE LIGATION; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; SINGLE DRUG DOSE; SWISS ALBINO MOUSE;

AMINO ACIDS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; HYPERALGESIA; LIGANDS; MALE; MICE; MORPHINE; NEURALGIA; PAIN MEASUREMENT; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 51549111390     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.03.017     Document Type: Article

References (68)

1. al-Ghoul W.M., Volsi G.L., Weinberg R.J., and Rustioni A. Glutamate immunocytochemistry in the dorsal horn after injury or stimulation of the sciatic nerve of rats. Brain Res Bull 30 (1993) 453-459
2. Anderson J.J., Rao S.P., Rowe B., Giracello D.R., Holtz G., Chapman D.F., et al. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4 yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. J Pharmacol Exp Ther 303 (2002) 1044-1051
3. Attucci S., Carlà V., Mannaioni G., and Moroni F. Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges. Br J Pharmacol 132 (2001) 799-806
4. Attwell P.J., Kaura S., Sigala G., Bradford H.F., Croucher M.J., Jane D.E., et al. Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Res 698 (1995) 155-162
5. Awad H., Hubert G.W., Smith Y., Levey A.I., and Conn P.J. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J Neurosci 20 (2000) 7871-7879
6. Battaglia G., Monn J.A., and Schoepp D.D. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neurosci Lett 229 (1997) 161-164
7. Benquet P., Gee C.E., and Gerber U.J. Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes. Neurosci 22 (2002) 9679-9686
8. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
9. Berenbaum M.C. What is synergy?. Pharmacol Rev 41 (1989) 93-141
10. Berthele A., Boxall S.J., Urban A., Anneser J.M., Zieglgansberger W., Urban L., et al. Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord. Brain Res Dev Brain Res 112 (1999) 39-53
11. Bhave G., Karim F., Carlton S.M., and Gereau IV R.W. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 4 (2001) 417-423
12. Bond A., Jones N.M., Hicks C.A., Whiffin G.M., Ward M.A., O'Neill M.F., et al. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo. J Pharmacol Exp Ther 294 (2000) 800-809
13. Carlton S.M., Hargett G.L., and Coggeshall R.E. Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105 (2001) 957-969
14. Carlton S.M., and Hargett G.L. Colocalization of metabotropic glutamate receptors in rat dorsal root ganglion cells. J Comp Neurol 501 (2007) 780-789
15. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
16. Chen S.R., and Pan H.L. Distinct roles of group III metabotropic glutamate receptors in control of nociception and dorsal horn neurons in normal and nerve-injured Rats. J Pharmacol Exp Ther 312 (2005) 120-126
17. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37 (1997) 205-237
18. Cozzi A., Attucci S., Peruginelli F., Marinozzi M., Luneia R., Pellicciari R., and Moroni F. Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1′S,2′S,3′R)-2-(2′-carboxy-3′-phenylcyclopropyl)glycine, a new potent and selective antagonist. Eur J Neurosci 9 (1997) 1350-1355
19. Dmitrieva N., Rodríguez-Malaver A.J., Pérez J., and Hernández L. Differential release of neurotransmitters from superficial and deep layers of the dorsal horn in response to acute noxious stimulation and inflammation of the rat paw. Eur J Pain 8 (2004) 245-252
20. Ding Y.Q., Kaneko T., Nomura S., and Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J Comp Neurol. 367 (1996) 375-402
21. Dolan S., Kelly J.G., Monteiro A.M., and Nolan A.M. Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia. Pain 106 (2003) 501-512
22. Fisher K., and Coderre T.J. Comparison of nociceptive effects produced by intrathecal administration of mGluR agonists. Neuroreport 7 (1996) 2743-2747
23. Fisher K., and Coderre T.J. The contribution of metabotropic glutamate receptors (mGluRs) to formalin-induced nociception. Pain 68 (1996) 255-263
24. Fundytus M.E., Fisher K., Dray A., Henry J.L., and Coderre T.J. In vivo antinociceptive activity of anti-rat mGluR1 and mGluR5 antibodies in rats. Neuroreport 9 (1998) 731-735
25. Fundytus M.E., Yashpal K., Chabot J.G., Osborne M.G., Lefebvre C.D., Dray A., et al. Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats. Br J Pharmacol 132 (2001) 354-367
26. Gasparini F., Lingenhöhl K., Stoehr N., Flor P.J., Heinrich M., Vranesic I., et al. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38 (1999) 1493-1503
27. Gerber G., Zhong J., Youn D., and Randic M. Group II and group III metabotropic glutamate receptor agonists depress synaptic transmission in the rat spinal cord dorsal horn. Neuroscience 100 (2000) 393-406
28. Glaum S.R., and Miller R.J. Inhibition of phosphoprotein phosphatases blocks metabotropic glutamate receptor effects in the rat nucleus tractus solitarii. Mol Pharmacol 45 (1994) 1221-1226
29. Hudson L.J., Bevan S., McNair K., Gentry C., Fox A., Kuhn R., et al. Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced cold hyperalgesia. J Neurosci 22 (2002) 2660-2668
30. Jones C.K., Eberle E.L., Peters S.C., Monn J.A., and Shannon H.E. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing. Neuropharmacology 49 (2005) 206-218
31. Kozela E., Pilc A., and Popik P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology (Berl) 165 (2003) 245-251
32. Li H., Ohishi H., Kinoshita A., Shigemoto R., Nomura S., and Mizuno N. Localization of a metabotropic glutamate receptor, mGluR7, in axon terminals of presumed nociceptive, primary afferent fibers in the superficial layers of the spinal dorsal horn: an electron microscope study in the rat. Neurosci Lett 223 (1997) 153-156
33. Lorrain D.S., Correa L., Anderson J., and Varney M. Activation of spinal group I metabotropic glutamate receptors in rats evokes local glutamate release and spontaneous nociceptive behaviors: effects of 2-methyl-6-(phenylethynyl)-pyridine pretreatment. Neurosci Lett 327 (2002) 198-202
34. Mao J., Price D.D., and Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61 (1995) 353-364
35. Mayer D.J., Mao J., Holt J., and Price D.D. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 96 (1999) 7731-7736
36. Mika J., Osikowicz M., Makuch W., and Przewlocka B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol. 560 (2007) 142-149
37. Mills C.D., Johnson K.M., and Hulsebosch C.E. Role of group II and group III metabotropic glutamate receptors in spinal cord injury. Exp Neurol. 173 (2002) 153-167
38. Mitsukawa K., Yamamoto R., Ofner S., Nozulak J., Pescott O., Lukic S., et al. A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc Natl Acad Sci U S A 102 (2005) 18712-18717
39. Monn J.A., Valli M.J., Johnson B.G., Salhoff C.R., Wright R.A., Howe T., et al. Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase. J Med Chem 39 (1996) 2990-3000
40. Narita M., Mizoguchi H., Kampine J.P., and Tseng L.F. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br J Pharmacol 118 (1996) 1829-1835
41. Narita M., Suzuki M., Narita M., Niikura K., Nakamura A., Miyatake M., et al. Involvement of spinal metabotropic glutamate receptor 5 in the development of tolerance to morphine-induced antinociception. J Neurochem 94 (2005) 1297-1305
42. Ohishi H., Nomura S., Ding Y.Q., Shigemoto R., Wada E., Kinoshita A., et al. Presynaptic localization of a metabotropic glutamate receptor, mGluR7, in the primary afferent neurons: an immunohistochemical study in the rat. Neurosci Lett 202 (1995) 85-88
43. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., and Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci Lett 199 (1995) 87-90
44. Pelkey K.A., Yuan X., Lavezzari G., Roche K.W., and McBain C.J. mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082. Neuropharmacology 52 (2007) 108-117
45. Petralia R.S., Wang Y.X., Niedzielski A.S., and Wenthold R.J. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience 71 (1996) 949-976
46. Pin J.P., and Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 (1995) 1-26
47. Pisani A., Gubellini P., Bonsi P., Conquet F., Picconi B., Centonze D., et al. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons. Neuroscience 106 (2001) 579-587
48. Pitcher M.H., Ribeiro-da-Silva A., and Coderre T.J. Effects of inflammation on the ultrastructural localization of spinal cord dorsal horn group I metabotropic glutamate receptors. J Comp Neurol 505 (2007) 412-423
49. Popik P., Kozela E., and Pilc A. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. Br J Pharmacol 130 (2000) 1425-1431
50. Porreca F., Tang Q.B., Bian D., Riedl M., Elde R., and Lai J. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res 795 (1998) 197-203
51. Przewlocka B., Mika J., Labuz D., Toth G., and Przewlocki R. Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur J Pharmacol. 367 (1999) 189-196
52. Sevostianova N., and Danysz W. Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test. Neuropharmacology 51 (2006) 623-630
53. Simmons R.M., Webster A.A., Kalra A.B., and Iyengar S. Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats. Pharmacol. Biochem. Behav. 73 (2002) 419-427
54. Smith G.D., Wiseman J., Harrison S.M., Elliott P.J., and Brich P.J. Pre treatment with MK-801, a non-competitive NMDA antagonist, prevents development of mechanical hyperalgesia in a rat model of chronic neuropathy, but not in a model of chronic inflammation. Neurosci Lett 165 (1994) 79-83
55. Sommer C., and Schäfers M. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res 784 (1998) 154-162
56. Sotgiu M.L., Bellomi P., and Biella G.E. The mGluR5 selective antagonist 6-methyl-2-(phenylethynyl)-pyridine reduces the spinal neuron pain-related activity in mononeuropathic rats. Neurosci Lett 342 (2003) 85-88
57. Stanfa L.C., and Dickenson A.H. Inflammation alters the effects of mGlu receptor agonists on spinal nociceptive neurones. Eur J Pharmacol 347 (1998) 165-172
58. Starowicz K., Bilecki W., Sieja A., Przewlocka B., and Przewlocki R. Melanocortin 4 receptor is expressed in the dorsal root ganglions and down-regulated in neuropathic rats. Neurosci Lett 358 (2004) 79-82
59. Tallarida R.J., and Murray R.B. Manual of Pharmacologic Calculations with Computer Programs (1987), Springer-Verlag, New York
60. Urban M.O., and Gebhart G.F. Central mechanisms in pain. Med Clin North Am 83 (1999) 585-596
61. Varney M.A., and Gereau R.W. Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics. Curr Drug Targets CNS Neurol Disord. 1 (2002) 283-296
62. Varty G.B., Grilli M., Forlani A., Fredduzzi S., Grzelak M.E., Guthrie D.H., et al. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology (Berl) 179 (2005) 207-217
63. Walker K., Reeve A., Bowes M., Winter J., Wotherspoon G., Davis A., et al. mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology 40 (2001) 10-19
64. Walker K., Bowes M., Panesar M., Davis A., Gentry C., Kesingland A., et al. Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology 40 (2001) 1-9
65. Young M.R., Fleetwood-Walker S.M., Dickinson T., Blackburn-Munro G., Sparrow H., Birch P.J., et al. Behavioural and electrophysiological evidence supporting a role for group I metabotropic glutamate receptors in the mediation of nociceptive inputs to the rat spinal cord. Brain Res 777 (1997) 161-169
66. Zhou S., Komak S., Du J., and Carlton S.M. Metabotropic glutamate 1alpha receptors on peripheral primary afferent fibers: their role in nociception. Brain Res 913 (2001) 18-26
67. Zhu C.Z., Wilson S.G., Mikusa J.P., Wismer C.T., Gauvin D.M., Lynch III J.J., et al. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol 506 (2004) 107-118
68. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110